4th Circ. Denies Eli Lilly's Discovery Bid In Novartis IP Feud
The Fourth Circuit on Thursday affirmed a Virginia district court's decision denying Eli Lilly's discovery bid related to Novartis' European patent suit over Eli Lilly's psoriasis drug Taltz, agreeing that Novartis...To view the full article, register now.
Already a subscriber? Click here to view full article